🇺🇸 FDA
Pipeline program

Atumelnant 120 mg tablets, Atumelnant 80 mg tablets, Tablet

CRN04894-12

Phase 3 small_molecule active

Quick answer

Atumelnant 120 mg tablets, Atumelnant 80 mg tablets, Tablet for Classic Congenital Adrenal Hyperplasia is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Classic Congenital Adrenal Hyperplasia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials